chazzledazzle,

Thanks for response. I was not very clear in my post. I wasn't really questioning the 2 doses vs. 4; I was using that as intro to the point in video where home administration was discussed. I was not clear about that one either. I didn't mean to ask if home administration had been discussed before. What I meant to ask was whether this was the first known instance of Leronlimab actually being administered in the home.

Agree with you that Sub-Q is a great advantage over the other MABs which are IV. Exciting times. That video was loaded with good information.